{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:13:54Z","timestamp":1783188834135,"version":"3.54.6"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T00:00:00Z","timestamp":1450051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministerio de Educaci\u00f3n y Ciencia (ES)","award":["BFU2010-17387"],"award-info":[{"award-number":["BFU2010-17387"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s11011-015-9777-7","type":"journal-article","created":{"date-parts":[[2015,12,13]],"date-time":"2015-12-13T23:57:29Z","timestamp":1450051049000},"page":"579-586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Impaired PLP-dependent metabolism in brain samples from Huntington disease patients and transgenic R6\/1 mice"],"prefix":"10.1007","volume":"31","author":[{"given":"M. Alba","family":"Sorolla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Rodr\u00edguez-Colman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Vall-llaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Vived","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Fern\u00e1ndez-Nogales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 J.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidre","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Cabiscol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,14]]},"reference":[{"key":"9777_CR1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.mehy.2010.09.003","volume":"76","author":"M Anitha","year":"2011","unstructured":"Anitha M, Nandhu MS, Anju TR, et al. (2011) Targeting glutamate mediated excitotoxicity in Huntington\u2019s disease: neural progenitors and partial glutamate antagonist\u2013memantine. Med Hypotheses 76:138\u2013140. doi: 10.1016\/j.mehy.2010.09.003","journal-title":"Med Hypotheses"},{"key":"9777_CR2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate M, Mitra S, Schweitzer ES, et al. (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431:805\u2013810 http:\/\/www.nature.com\/nature\/journal\/v431\/n7010\/suppinfo\/nature02998_S1.html","journal-title":"Nature"},{"key":"9777_CR3","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1212\/WNL.28.12.1280","volume":"28","author":"AN Barr","year":"1978","unstructured":"Barr AN, Heinze W, Mendoza JE, Perlik S (1978) Long term treatment of huntington disease with L-glutamate and pyridoxine. Neurology 28:1280\u20131282","journal-title":"Neurology"},{"issue":"4","key":"9777_CR4","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1046\/j.1471-4159.2003.01910.x","volume":"86","author":"G Battaglioli","year":"2003","unstructured":"Battaglioli G, Liu H, Martin DL (2003) Kinetic differences between the isoforms of glutamate decarboxylase: implications for the regulation of GABA synthesis. J Neurochem 86(4):879\u2013887. doi: 10.1046\/j.1471-4159.2003.01910.x","journal-title":"J Neurochem"},{"key":"9777_CR5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/BF00211028","volume":"94","author":"J Benitez","year":"1994","unstructured":"Benitez J, Fernandez E, Ruiz PG, et al. (1994) Trinucleotide (CAG) repeat expansion in chromosomes of Spanish patients with Huntington\u2019s disease. Hum Genet 94:563\u2013564. doi: 10.1007\/BF00211028","journal-title":"Hum Genet"},{"key":"9777_CR6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1196\/annals.1427.018","volume":"1147","author":"SE Browne","year":"2008","unstructured":"Browne SE (2008) Mitochondria and Huntington\u2019s disease pathogenesis: insight from genetic and chemical models. Ann N Y Acad Sci 1147:358\u2013382. doi: 10.1196\/annals.1427.018","journal-title":"Ann N Y Acad Sci"},{"key":"9777_CR7","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1021\/pr2000336","volume":"10","author":"KL Chang","year":"2011","unstructured":"Chang KL, New LS, Mal M, et al. (2011) Metabolic profiling of 3-nitropropionic acid early-stage Huntington\u2019s disease rat model using gas chromatography time-of-flight mass spectrometry. J Proteome Res 10:2079\u20132087. doi: 10.1021\/pr2000336","journal-title":"J Proteome Res"},{"key":"9777_CR8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neulet.2005.05.065","volume":"386","author":"YS Choo","year":"2005","unstructured":"Choo YS, Mao Z, Johnson GVW, Lesort M (2005) Increased glutathione levels in cortical and striatal mitochondria of the R6\/2 Huntington\u2019s disease mouse model. Neurosci Lett 386:63\u201368. doi: 10.1016\/j.neulet.2005.05.065","journal-title":"Neurosci Lett"},{"key":"9777_CR9","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, et al. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993. doi: 10.1126\/science.277.5334.1990","journal-title":"Science"},{"key":"9777_CR10","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1523\/JNEUROSCI.15-10-06377.1995","volume":"15","author":"LL Dugan","year":"1995","unstructured":"Dugan LL, Sensi SL, Canzoniero LM, et al. (1995) Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J Neurosci 15:6377\u20136388","journal-title":"J Neurosci"},{"key":"9777_CR11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"Group THDCR","year":"1993","unstructured":"Group THDCR (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"9777_CR12","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","volume":"43","author":"BG Jenkins","year":"1993","unstructured":"Jenkins BG, Koroshetz WJ, Beal MF, Rosen BR (1993) Evidence for impairment of energy metabolism in vivo in Huntington\u2019s disease using localized 1\u00a0H NMR spectroscopy. Neurology 43:2689\u20132695","journal-title":"Neurology"},{"key":"9777_CR13","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1021\/pr200132s","volume":"10","author":"M Jov\u00e9","year":"2011","unstructured":"Jov\u00e9 M, Serrano JCE, Ortega N, et al. (2011) Multicompartmental LC-Q-TOF-based metabonomics as an exploratory tool to identify novel pathways affected by polyphenol-rich diets in mice. J Proteome Res 10:3501\u20133512. doi: 10.1021\/pr200132s","journal-title":"J Proteome Res"},{"key":"9777_CR14","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1007\/s00415-007-0611-y","volume":"254","author":"N Klepac","year":"2007","unstructured":"Klepac N, Relja M, Klepac R, et al. (2007) Oxidative stress parameters in plasma of Huntington\u2019s disease patients, asymptomatic Huntington\u2019s disease gene carriers and healthy subjects\u202f: a cross-sectional study. J Neurol 254:1676\u20131683. doi: 10.1007\/s00415-007-0611-y","journal-title":"J Neurol"},{"key":"9777_CR15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"issue":"2","key":"9777_CR16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00966814","volume":"19","author":"L Massieu","year":"1994","unstructured":"Massieu L, Rivera A, Tapia R (1994) Convulsions and inhibition of glutamate decarboxylase by pyridoxal phosphate-gamma-glutamyl hydrazone in the developing rat. Neurochem Res 19(2):183\u2013187","journal-title":"Neurochem Res"},{"key":"9777_CR17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm1366","volume":"12","author":"PB Mills","year":"2006","unstructured":"Mills PB, Struys E, Jakobs C, et al. (2006) Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med 12:307\u2013309. doi: 10.1038\/nm1366","journal-title":"Nat Med"},{"key":"9777_CR18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM197302152880703","volume":"288","author":"TL Perry","year":"1973","unstructured":"Perry TL, Hansen S, Kloster M (1973) Huntington\u2019s chorea. Deficiency of gamma-aminobutyric acid in brain. N Engl J Med 288:337\u2013342. doi: 10.1056\/nejm197302152880703","journal-title":"N Engl J Med"},{"key":"9777_CR19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0968-0004(98)01350-4","volume":"24","author":"MF Perutz","year":"1999","unstructured":"Perutz MF (1999) Glutamine repeats and neurodegenerative diseases: molecular aspects. Trends Biochem Sci 24:58\u201363. doi: 10.1016\/S0968-0004(98)01350-4","journal-title":"Trends Biochem Sci"},{"key":"9777_CR20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1469-8749.2007.00300.x","volume":"49","author":"PM Rankin","year":"2007","unstructured":"Rankin PM, Harrison S, Chong WK, et al. (2007) Pyridoxine-dependent seizures: a family phenotype that leads to severe cognitive deficits, regardless of treatment regime. Dev Med Child Neurol 49:300\u2013305. doi: 10.1111\/j.1469-8749.2007.00300.x","journal-title":"Dev Med Child Neurol"},{"key":"9777_CR21","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner A, Albin RL, Anderson KD, et al. (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A 85:5733\u20135737","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9777_CR22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0304-3940(87)90639-2","volume":"78","author":"GP Reynolds","year":"1987","unstructured":"Reynolds GP, Pearson SJ (1987) Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington\u2019s disease brain. Neurosci Lett 78:233\u2013238","journal-title":"Neurosci Lett"},{"key":"9777_CR23","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","volume":"20","author":"U Shirendeb","year":"2011","unstructured":"Shirendeb U, Reddy AP, Manczak M, et al. (2011) Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: implications for selective neuronal damage. Hum Mol Genet 20:1438\u20131455. doi: 10.1093\/hmg\/ddr024","journal-title":"Hum Mol Genet"},{"key":"9777_CR24","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2008.05.014","volume":"45","author":"MA Sorolla","year":"2008","unstructured":"Sorolla MA, Reverter-Branchat G, Tamarit J, et al. (2008) Proteomic and oxidative stress analysis in human brain samples of Huntington disease. Free Radic Biol Med 45:667\u2013678. doi: 10.1016\/j.freeradbiomed.2008.05.014","journal-title":"Free Radic Biol Med"},{"key":"9777_CR25","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.freeradbiomed.2010.05.016","volume":"49","author":"MA Sorolla","year":"2010","unstructured":"Sorolla MA, Rodr\u00edguez-Colman MJ, Tamarit J, et al. (2010) Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism. Free Radic Biol Med 49:612\u2013621. doi: 10.1016\/j.freeradbiomed.2010.05.016","journal-title":"Free Radic Biol Med"},{"key":"9777_CR26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/biof.1013","volume":"38","author":"MA Sorolla","year":"2012","unstructured":"Sorolla MA, Rodr\u00edguez-Colman MJ, Vall-Llaura N, et al. (2012) Protein oxidation in Huntington disease. Biofactors 38:173\u2013185. doi: 10.1002\/biof.1013","journal-title":"Biofactors"},{"key":"9777_CR27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","volume":"45","author":"SJ Tabrizi","year":"1999","unstructured":"Tabrizi SJ, Cleeter MW, Xuereb J, et al. (1999) Biochemical abnormalities and excitotoxicity in Huntington\u2019s disease brain. Ann Neurol 45:25\u201332 ISSN: 0364-5134","journal-title":"Ann Neurol"},{"key":"9777_CR28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/pr050244o","volume":"5","author":"TM Tsang","year":"2006","unstructured":"Tsang TM, Woodman B, McLoughlin GA, et al. (2006) Metabolic characterization of the R6\/2 transgenic mouse model of Huntington\u2019s disease by high-resolution MAS 1H NMR spectroscopy. J Proteome Res 5:483\u2013492. doi: 10.1021\/pr050244o","journal-title":"J Proteome Res"},{"key":"9777_CR29","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s11064-008-9904-5","volume":"34","author":"TM Tsang","year":"2009","unstructured":"Tsang TM, Haselden JN, Holmes E (2009) Metabonomic characterization of the 3-nitropropionic acid rat model of Huntington\u2019s disease. Neurochem Res 34:1261\u20131271. doi: 10.1007\/s11064-008-9904-5","journal-title":"Neurochem Res"},{"key":"9777_CR30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, et al. (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"9777_CR31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0022-510X(80)90028-3","volume":"47","author":"A Zanella","year":"1980","unstructured":"Zanella A, Izzo C, Meola G, et al. (1980) Metabolic impairment and membrane abnormality in red cells from Huntington\u2019s disease. J Neurol Sci 47:93\u2013103","journal-title":"J Neurol Sci"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-015-9777-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-015-9777-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-015-9777-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T08:34:56Z","timestamp":1567413296000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-015-9777-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,14]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["9777"],"URL":"https:\/\/doi.org\/10.1007\/s11011-015-9777-7","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,14]]}}}